Kodiak Sciences, Inc. (KOD)
85.75
-2.37
(-2.69%)
USD |
NASDAQ |
Oct 16, 16:00
85.59
-0.16
(-0.19%)
After-Hours: 20:00
Kodiak Sciences Research and Development Expense (Annual) : 182.37M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 182.37M |
| December 31, 2024 | 126.10M |
| December 31, 2023 | 206.30M |
| December 31, 2022 | 267.59M |
| December 31, 2021 | 217.34M |
| Date | Value |
|---|---|
| December 31, 2020 | 107.39M |
| December 31, 2019 | 37.51M |
| December 31, 2018 | 18.79M |
| December 31, 2017 | 22.02M |
| December 31, 2016 | 14.05M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| AbbVie, Inc. | 8.249B |
| Mirum Pharmaceuticals, Inc. | 185.83M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |